The global ventricular assist device market reached a value of nearly $1,701.2 million in 2022, having grown at a compound annual growth rate (CAGR) of 9.3% since 2017. The market is expected to grow from $1,701.2 million in 2022 to $3,003.1 million in 2027 at a rate of 12.0%. The market is then expected to grow at a CAGR of 12.0% from 2027 and reach $5,295.8 million in 2032.
Growth in the historic period resulted from an increase in the prevalence of heart failure and a rise in demand for organ transplantation procedures.
Going forward, the increasing need for destination therapy, aging population, increasing healthcare expenditure and a rise in awareness regarding heart failure treatment will drive the growth. Factors that could hinder the growth of the ventricular assist device market in the future include side effects associated with ventricular assist devices.
The ventricular assist device market is segmented by product into left ventricular assist devices (LVADs), right ventricular assist devices (RVADs) and biventricular assist devices (BIVADs). The left ventricular assist devices (LVADs) market was the largest segment of the ventricular assist device market segmented by product accounting for 84.9% of the total in 2022. Going forward, the biventricular assist devices (BIVADs) market is expected to be the fastest growing segment in the ventricular assist device market segmented by product, at a CAGR of 13.0% during 2022-2027.
The ventricular assist device market is segmented by type into pulsatile flow and continuous flow. The continuous flow market was the largest segment of the ventricular assist device market segmented type accounting for 90.0% of the total in 2022. Going forward, the pulsatile flow market is expected to be the fastest growing segment in the ventricular assist device market segmented by type, at a CAGR of 13.1% during 2022-2027.
The ventricular assist device market is segmented by design into transcutaneous ventricular assist devices and implantable ventricular assist devices. The implantable ventricular assist devices market was the largest segment of the ventricular assist device market segmented by design accounting for 75.0% of the total in 2022. Going forward, the implantable ventricular assist devices market is expected to be the fastest growing segment in the ventricular assist device market segmented by design, at a CAGR of 12.5% during 2022-2027.
The ventricular assist device market is segmented by application into bridge-to-transplant (BTT) therapy, destination therapy, bridge-to-recovery (BTR) therapy and bridge-to-candidacy (BTC) therapy. The destination therapy market was the largest segment of the ventricular assist device market segmented by application accounting for 45.2% of the total in 2022. Going forward, the bridge-to-transplant (BTT) therapy market is expected to be the fastest growing segment in the ventricular assist device market segmented by application, at a CAGR of 12.6% during 2022-2027.
The ventricular assist device market is segmented by end user into hospitals, ambulatory surgical centers and cardiology centers. The hospitals market was the largest segment of the ventricular assist device market segmented by end user accounting for 69.9% of the total in 2022. Going forward, the hospitals market is expected to be the fastest growing segment in the ventricular assist device market segmented by end user, at a CAGR of 12.3% during 2022-2027.
North America was the largest region in the ventricular assist device market, accounting for 37.3% of the total in 2022. It was followed by Western Europe, and then the other regions. Going forward, the fastest-growing regions in the ventricular assist device market will be Asia Pacific, and Middle East where growth will be at CAGRs of 23.6% and 5.2% respectively. These will be followed by South America, and Eastern Europe where the markets are expected to grow at CAGRs of 5.2% and 2.8% respectively.
The global ventricular assist device market is concentrated, with a few large players. The top ten competitors in the market made up to 53.22% of the total market in 2021. Technological innovations in the recent past helped the companies to strengthen their market presence. Abiomed was the largest competitor with 19.62% share of the market, followed by Abbott Laboratories with 14.76%, Medtronic with 7.85%, LivaNova PLC with 3.32%, Terumo Corporation with 2.85%, Berlin Heart GmbH with 1.46%, Cirtec with 1.37%, Jarvik Heart Inc. with 0.86%, SynCardia Systems, LLC. with 0.80% and Calon Cardio-Technology Ltd with 0.33%.
The top opportunities in the ventricular assist device market segmented by product will arise in the left ventricular assist devices (LVADs) segment, which will gain $1,106.5 million of global annual sales by 2027. The top opportunities in the ventricular assist device market segmented by type will arise in the continuous flow segment, which will gain $1,157.8 million of global annual sales by 2027. The top opportunities in segment by design will arise in the implantable ventricular assist devices segment, which will gain $1,026.7 million of global annual sales by 2027. The top opportunities in segment by application will arise in the destination therapy segment, which will gain $587.0 million of global annual sales by 2027. The top opportunities in segment by end user will arise in the hospitals segment, which will gain $931.0 million of global annual sales by 2027. The ventricular assist device market size will gain the most in the USA at $1,053.1 million.
Market-trend-based strategies for the ventricular assist device market include focus on lengthening effective life of VADs, miniaturization of VADs, advanced pump technologies, increased focus on VAD safety and effectiveness, focus on reduction in side effects of VADs and percutaneously inserted ventricular assist devices.
Player-adopted strategies in the ventricular assist device market include focus on enhancing business operations through receiving regulatory approvals, focus on providing innovative solutions and focus on making life-saving technology more accessible to critically ill patients.
To take advantage of the opportunities, the publisher recommends the ventricular assist device companies to focus on advanced pump technologies, invest in percutaneously inserted ventricular assist devices, focus on VAD safety and effectiveness, expand in emerging markets, continue to focus on developed markets, focus on partnerships and collaborations, provide competitively priced offerings, participate in trade shows and events, focus on aging population and continue to target fast-growing end-users.
This report describes and explains the ventricular assist device market and covers 2017-2022, termed the historic period, and 2022-2027 termed the forecast period, along with further forecasts for the period 2027-2032. The report evaluates the market across each region and for the major economies within each region.
Growth in the historic period resulted from an increase in the prevalence of heart failure and a rise in demand for organ transplantation procedures.
Going forward, the increasing need for destination therapy, aging population, increasing healthcare expenditure and a rise in awareness regarding heart failure treatment will drive the growth. Factors that could hinder the growth of the ventricular assist device market in the future include side effects associated with ventricular assist devices.
The ventricular assist device market is segmented by product into left ventricular assist devices (LVADs), right ventricular assist devices (RVADs) and biventricular assist devices (BIVADs). The left ventricular assist devices (LVADs) market was the largest segment of the ventricular assist device market segmented by product accounting for 84.9% of the total in 2022. Going forward, the biventricular assist devices (BIVADs) market is expected to be the fastest growing segment in the ventricular assist device market segmented by product, at a CAGR of 13.0% during 2022-2027.
The ventricular assist device market is segmented by type into pulsatile flow and continuous flow. The continuous flow market was the largest segment of the ventricular assist device market segmented type accounting for 90.0% of the total in 2022. Going forward, the pulsatile flow market is expected to be the fastest growing segment in the ventricular assist device market segmented by type, at a CAGR of 13.1% during 2022-2027.
The ventricular assist device market is segmented by design into transcutaneous ventricular assist devices and implantable ventricular assist devices. The implantable ventricular assist devices market was the largest segment of the ventricular assist device market segmented by design accounting for 75.0% of the total in 2022. Going forward, the implantable ventricular assist devices market is expected to be the fastest growing segment in the ventricular assist device market segmented by design, at a CAGR of 12.5% during 2022-2027.
The ventricular assist device market is segmented by application into bridge-to-transplant (BTT) therapy, destination therapy, bridge-to-recovery (BTR) therapy and bridge-to-candidacy (BTC) therapy. The destination therapy market was the largest segment of the ventricular assist device market segmented by application accounting for 45.2% of the total in 2022. Going forward, the bridge-to-transplant (BTT) therapy market is expected to be the fastest growing segment in the ventricular assist device market segmented by application, at a CAGR of 12.6% during 2022-2027.
The ventricular assist device market is segmented by end user into hospitals, ambulatory surgical centers and cardiology centers. The hospitals market was the largest segment of the ventricular assist device market segmented by end user accounting for 69.9% of the total in 2022. Going forward, the hospitals market is expected to be the fastest growing segment in the ventricular assist device market segmented by end user, at a CAGR of 12.3% during 2022-2027.
North America was the largest region in the ventricular assist device market, accounting for 37.3% of the total in 2022. It was followed by Western Europe, and then the other regions. Going forward, the fastest-growing regions in the ventricular assist device market will be Asia Pacific, and Middle East where growth will be at CAGRs of 23.6% and 5.2% respectively. These will be followed by South America, and Eastern Europe where the markets are expected to grow at CAGRs of 5.2% and 2.8% respectively.
The global ventricular assist device market is concentrated, with a few large players. The top ten competitors in the market made up to 53.22% of the total market in 2021. Technological innovations in the recent past helped the companies to strengthen their market presence. Abiomed was the largest competitor with 19.62% share of the market, followed by Abbott Laboratories with 14.76%, Medtronic with 7.85%, LivaNova PLC with 3.32%, Terumo Corporation with 2.85%, Berlin Heart GmbH with 1.46%, Cirtec with 1.37%, Jarvik Heart Inc. with 0.86%, SynCardia Systems, LLC. with 0.80% and Calon Cardio-Technology Ltd with 0.33%.
The top opportunities in the ventricular assist device market segmented by product will arise in the left ventricular assist devices (LVADs) segment, which will gain $1,106.5 million of global annual sales by 2027. The top opportunities in the ventricular assist device market segmented by type will arise in the continuous flow segment, which will gain $1,157.8 million of global annual sales by 2027. The top opportunities in segment by design will arise in the implantable ventricular assist devices segment, which will gain $1,026.7 million of global annual sales by 2027. The top opportunities in segment by application will arise in the destination therapy segment, which will gain $587.0 million of global annual sales by 2027. The top opportunities in segment by end user will arise in the hospitals segment, which will gain $931.0 million of global annual sales by 2027. The ventricular assist device market size will gain the most in the USA at $1,053.1 million.
Market-trend-based strategies for the ventricular assist device market include focus on lengthening effective life of VADs, miniaturization of VADs, advanced pump technologies, increased focus on VAD safety and effectiveness, focus on reduction in side effects of VADs and percutaneously inserted ventricular assist devices.
Player-adopted strategies in the ventricular assist device market include focus on enhancing business operations through receiving regulatory approvals, focus on providing innovative solutions and focus on making life-saving technology more accessible to critically ill patients.
To take advantage of the opportunities, the publisher recommends the ventricular assist device companies to focus on advanced pump technologies, invest in percutaneously inserted ventricular assist devices, focus on VAD safety and effectiveness, expand in emerging markets, continue to focus on developed markets, focus on partnerships and collaborations, provide competitively priced offerings, participate in trade shows and events, focus on aging population and continue to target fast-growing end-users.
This report describes and explains the ventricular assist device market and covers 2017-2022, termed the historic period, and 2022-2027 termed the forecast period, along with further forecasts for the period 2027-2032. The report evaluates the market across each region and for the major economies within each region.
Table of Contents
1. Executive Summary2. Table Of Contents
3. List Of Figures
4. List Of Tables
5. Report Structure
6. Introduction and Market Characteristics
6.1. General Market Definition
6.2. Summary
6.3. Ventricular Assist Device Market Definition And Segmentations
6.4. Market Segmentation By Product
6.4.1. Left Ventricular Assist Devices (LVADs)
6.4.2. Right Ventricular Assist Devices (RVADs)
6.4.3. Biventricular Assist Devices (BIVADs)
6.5. Market Segmentation By Type
6.5.1. Pulsatile Flow
6.5.2. Continuous Flow
6.6. Market Segmentation By Design
6.6.1. Transcutaneous Ventricular Assist Devices
6.6.2. Implantable Ventricular Assist Devices
6.7. Market Segmentation By Application
6.7.1. Bridge-To-Transplant (BTT) Therapy
6.7.2. Destination Therapy
6.7.3. Bridge-To-Recovery (BTR) Therapy
6.7.4. Bridge-To-Candidacy (BTC) Therapy
6.8. Market Segmentation By End User
6.8.1. Hospitals
6.8.2. Ambulatory Surgical Centers
6.8.3. Cardiology Centers
7. Major Market Trends
7.1. Focus On Lengthening Effective Life Of VADs
7.2. Miniaturization Of VADs
7.3. Advanced Pump Technologies
7.4. Increased Focus On VAD Safety And Effectiveness
7.5. Reduction In Side Effects Of VADs
7.6. Percutaneously Inserted Ventricular Assist Devices
8. Global Market Size and Growth
8.1. Market Size
8.2. Historic Market Growth, 2017 - 2022, Value ($ Million)
8.2.1. Market Drivers 2017 - 2022
8.2.2. Market Restraints 2017 - 2022
8.3. Forecast Market Growth, 2022 - 2027, 2032F Value ($ Million)
8.3.1. Market Drivers 2022 - 2027
8.3.2. Market Restraints 2022 - 2027
9. Global Ventricular Assist Device Market Segmentation
9.1. Global Ventricular Assist Device Market, Segmentation By Product, Historic And Forecast, 2017 - 2022, 2027F, 2032F, Value ($ Million)
9.2. Global Ventricular Assist Device Market, Segmentation By Type, Historic And Forecast, 2017 - 2022, 2027F, 2032F, Value ($ Million)
9.3. Global Ventricular Assist Device Market, Segmentation By Design, Historic And Forecast, 2017 - 2022, 2027F, 2032F, Value ($ Million)
9.4. Global Ventricular Assist Device Market, Segmentation By Application, Historic And Forecast, 2017 - 2022, 2027F, 2032F, Value ($ Million)
9.5. Global Ventricular Assist Device Market, Segmentation By End User, Historic And Forecast, 2017 - 2022, 2027F, 2032F, Value ($ Million)
10. Ventricular Assist Device Market, Regional and Country Analysis
10.1. Global Ventricular Assist Device Market, By Region, Historic and Forecast, 2017 - 2022, 2027F, 2032F, Value ($ Million)
10.2. Global Ventricular Assist Device Market, By Country, Historic and Forecast, 2017 - 2022, 2027F, 2032F, Value ($ Million)
11. Asia-Pacific Market
11.1. Summary
11.2. Market Overview
11.2.1. Region Information
11.2.2. Market Information
11.2.3. Background Information
11.2.4. Government Initiatives
11.2.5. Regulations
11.2.6. Regulatory Bodies
11.2.7. Major Associations
11.2.8. Taxes levied
11.2.9. Corporate Tax Structure
11.2.10. Investments
11.2.11. Major Companies
11.3. Asia-Pacific Ventricular Assist Device Market, Historic Market Growth, 2017 - 2022, Value ($ Million)
11.4. Asia-Pacific Ventricular Assist Device Market, Forecast Market Growth, 2022 - 2027, 2032F Value ($ Million)
11.5. Asia-Pacific Ventricular Assist Device Market, Segmentation By Product, Historic And Forecast, 2017 - 2022, 2027F, 2032F, Value ($ Million)
11.6. Asia-Pacific Ventricular Assist Device Market, Segmentation By Application, Historic And Forecast, 2017 - 2022, 2027F, 2032F, Value ($ Million)
11.7. Asia-Pacific Ventricular Assist Device Market, Segmentation By End User, Historic And Forecast, 2017 - 2022, 2027F, 2032F, Value ($ Million)
11.8. Asia-Pacific Ventricular Assist Device Market: Country Analysis
11.9. China Market
11.10. Summary
11.11. Market Overview
11.11.1. Country Information
11.11.2. Market Information
11.11.3. Background Information
11.11.4. Government Initiatives
11.11.5. Regulations
11.11.6. Regulatory Bodies
11.11.7. Major Associations
11.11.8. Taxes Levied
11.11.9. Corporate tax structure
11.11.10. Investments
11.11.11. Major Companies
11.12. China Ventricular Assist Device Market, Historic Market Growth, 2017 - 2022, Value ($ Million)
11.13. China Ventricular Assist Device Market, Forecast Market Growth, 2022 - 2027, 2032F Value ($ Million)
11.14. China Ventricular Assist Device Market, Segmentation By Product, Historic And Forecast, 2017 - 2022, 2027F, 2032F, Value ($ Million)
11.15. China Ventricular Assist Device Market, Segmentation By Application, Historic And Forecast, 2017 - 2022, 2027F, 2032F, Value ($ Million)
11.16. China Ventricular Assist Device Market, Segmentation By End User, Historic And Forecast, 2017 - 2022, 2027F, 2032F, Value ($ Million)
11.17. India Market
11.18. India Ventricular Assist Device Market, Historic Market Growth, 2017 - 2022, Value ($ Million)
11.19. India Ventricular Assist Device Market, Forecast Market Growth, 2022 - 2027, 2032F Value ($ Million)
11.20. India Ventricular Assist Device Market, Segmentation By Product, Historic And Forecast, 2017 - 2022, 2027F, 2032F, Value ($ Million)
11.21. India Ventricular Assist Device Market, Segmentation By Application, Historic And Forecast, 2017 - 2022, 2027F, 2032F, Value ($ Million)
11.22. India Ventricular Assist Device Market, Segmentation By End User, Historic And Forecast, 2017 - 2022, 2027F, 2032F, Value ($ Million)
11.23. Japan Market
11.24. Japan Ventricular Assist Device Market, Historic Market Growth, 2017 - 2022, Value ($ Million)
11.25. Japan Ventricular Assist Device Market, Forecast Market Growth, 2022 - 2027, 2032F Value ($ Million)
11.26. Japan Ventricular Assist Device Market, Segmentation By Product, Historic And Forecast, 2017 - 2022, 2027F, 2032F, Value ($ Million)
11.27. Japan Ventricular Assist Device Market, Segmentation By Application, Historic And Forecast, 2017 - 2022, 2027F, 2032F, Value ($ Million)
11.28. Japan Ventricular Assist Device Market, Segmentation By End User, Historic And Forecast, 2017 - 2022, 2027F, 2032F, Value ($ Million)
11.29. Australia Market
11.30. Australia Ventricular Assist Device Market, Historic Market Growth, 2017 - 2022, Value ($ Million)
11.31. Australia Ventricular Assist Device Market, Forecast Market Growth, 2022 - 2027, 2032F Value ($ Million)
11.32. Australia Ventricular Assist Device Market, Segmentation By Product, Historic And Forecast, 2017 - 2022, 2027F, 2032F, Value ($ Million)
11.33. Australia Ventricular Assist Device Market, Segmentation By Application, Historic And Forecast, 2017 - 2022, 2027F, 2032F, Value ($ Million)
11.34. Australia Ventricular Assist Device Market, Segmentation By End User, Historic And Forecast, 2017 - 2022, 2027F, 2032F, Value ($ Million)
11.35. Indonesia Market
11.36. Indonesia Ventricular Assist Device Market, Historic Market Growth, 2017 - 2022, Value ($ Million)
11.37. Indonesia Ventricular Assist Device Market, Forecast Market Growth, 2022 - 2027, 2032F Value ($ Million)
11.38. Indonesia Ventricular Assist Device Market, Segmentation By Product, Historic And Forecast, 2017 - 2022, 2027F, 2032F, Value ($ Million)
11.39. Indonesia Ventricular Assist Device Market, Segmentation By Application, Historic And Forecast, 2017 - 2022, 2027F, 2032F, Value ($ Million)
11.40. Indonesia Ventricular Assist Device Market, Segmentation By End User, Historic And Forecast, 2017 - 2022, 2027F, 2032F, Value ($ Million)
11.41. South Korea Market
11.42. South Korea Ventricular Assist Device Market, Historic Market Growth, 2017 - 2022, Value ($ Million)
11.43. South Korea Ventricular Assist Device Market, Forecast Market Growth, 2022 - 2027, 2032F Value ($ Million)
11.44. South Korea Ventricular Assist Device Market, Segmentation By Product, Historic And Forecast, 2017 - 2022, 2027F, 2032F, Value ($ Million)
11.45. South Korea Ventricular Assist Device Market, Segmentation By Application, Historic And Forecast, 2017 - 2022, 2027F, 2032F, Value ($ Million)
11.46. South Korea Ventricular Assist Device Market, Segmentation By End User, Historic And Forecast, 2017 - 2022, 2027F, 2032F, Value ($ Million)
12. Western Europe Market
12.1. Summary
12.2. Market Overview
12.2.1. Region Information
12.2.2. Market Information
12.2.3. Background Information
12.2.4. Government Initiatives
12.2.5. Regulations
12.2.6. European Union
12.2.7. Regulatory bodies
12.2.8. Major Associations
12.2.9. Taxes Levied
12.2.10. Corporate Tax Structure
12.2.11. Investments
12.2.12. Major Companies
12.3. Western Europe Ventricular Assist Device Market, Historic Market Growth, 2017 - 2022, Value ($ Million)
12.4. Western Europe Ventricular Assist Device Market, Forecast Market Growth, 2022 - 2027, 2032F Value ($ Million)
12.5. Western Europe Ventricular Assist Device Market, Segmentation By Product, Historic And Forecast, 2017 - 2022, 2027F, 2032F, Value ($ Million)
12.6. Western Europe Ventricular Assist Device Market, Segmentation By Application, Historic And Forecast, 2017 - 2022, 2027F, 2032F, Value ($ Million)
12.7. Western Europe Ventricular Assist Device Market, Segmentation By End User, Historic And Forecast, 2017 - 2022, 2027F, 2032F, Value ($ Million)
12.8. Western Europe Ventricular Assist Device Market: Country Analysis
12.9. UK Market
12.10. UK Ventricular Assist Device Market, Historic Market Growth, 2017 - 2022, Value ($ Million)
12.11. UK Ventricular Assist Device Market, Forecast Market Growth, 2022 - 2027, 2032F Value ($ Million)
12.12. UK Ventricular Assist Device Market, Segmentation By Product, Historic And Forecast, 2017 - 2022, 2027F, 2032F, Value ($ Million)
12.13. UK Ventricular Assist Device Market, Segmentation By Application, Historic And Forecast, 2017 - 2022, 2027F, 2032F, Value ($ Million)
12.14. UK Ventricular Assist Device Market, Segmentation By End User, Historic And Forecast, 2017 - 2022, 2027F, 2032F, Value ($ Million)
12.15. Germany Market
12.16. Germany Ventricular Assist Device Market, Historic Market Growth, 2017 - 2022, Value ($ Million)
12.17. Germany Ventricular Assist Device Market, Forecast Market Growth, 2022 - 2027, 2032F Value ($ Million)
12.18. Germany Ventricular Assist Device Market, Segmentation By Product, Historic And Forecast, 2017 - 2022, 2027F, 2032F, Value ($ Million)
12.19. Germany Ventricular Assist Device Market, Segmentation By Application, Historic And Forecast, 2017 - 2022, 2027F, 2032F, Value ($ Million)
12.20. Germany Ventricular Assist Device Market, Segmentation By End User, Historic And Forecast, 2017 - 2022, 2027F, 2032F, Value ($ Million)
12.21. France Market
12.22. France Ventricular Assist Device Market, Historic Market Growth, 2017 - 2022, Value ($ Million)
12.23. France Ventricular Assist Device Market, Forecast Market Growth, 2022 - 2027, 2032F Value ($ Million)
12.24. France Ventricular Assist Device Market, Segmentation By Product, Historic And Forecast, 2017 - 2022, 2027F, 2032F, Value ($ Million)
12.25. France Ventricular Assist Device Market, Segmentation By Application, Historic And Forecast, 2017 - 2022, 2027F, 2032F, Value ($ Million)
12.26. France Ventricular Assist Device Market, Segmentation By End User, Historic And Forecast, 2017 - 2022, 2027F, 2032F, Value ($ Million)
13. Eastern Europe Market
13.1. Summary
13.2. Market Overview
13.2.1. Region Information
13.2.2. Market Information
13.2.3. Background Information
13.2.4. Government Initiatives
13.2.5. Regulations
13.2.6. Regulatory bodies
13.2.7. Major Associations
13.2.8. Taxes Levied
13.2.9. Corporate Tax Structure
13.2.10. Major Companies
13.3. Eastern Europe Ventricular Assist Device Market, Historic Market Growth, 2017 - 2022, Value ($ Million)
13.4. Eastern Europe Ventricular Assist Device Market, Forecast Market Growth, 2022 - 2027, 2032F Value ($ Million)
13.5. Eastern Europe Ventricular Assist Device Market, Segmentation By Product, Historic And Forecast, 2017 - 2022, 2027F, 2032F, Value ($ Million)
13.6. Eastern Europe Ventricular Assist Device Market, Segmentation By Application, Historic And Forecast, 2017 - 2022, 2027F, 2032F, Value ($ Million)
13.7. Eastern Europe Ventricular Assist Device Market, Segmentation By End User, Historic And Forecast, 2017 - 2022, 2027F, 2032F, Value ($ Million)
13.8. Eastern Europe Ventricular Assist Device Market: Country Analysis
13.9. Russia Market
13.10. Russia Ventricular Assist Device Market, Historic Market Growth, 2017 - 2022, Value ($ Million)
13.11. Russia Ventricular Assist Device Market, Forecast Market Growth, 2022 - 2027, 2032F Value ($ Million)
13.12. Russia Ventricular Assist Device Market, Segmentation By Product, Historic And Forecast, 2017 - 2022, 2027F, 2032F, Value ($ Million)
13.13. Russia Ventricular Assist Device Market, Segmentation By Application, Historic And Forecast, 2017 - 2022, 2027F, 2032F, Value ($ Million)
13.14. Russia Ventricular Assist Device Market, Segmentation By End User, Historic And Forecast, 2017 - 2022, 2027F, 2032F, Value ($ Million)
14. North America Market
14.1. Summary
14.2. Market Overview
14.2.1. Region Information
14.2.2. Market Information
14.2.3. Background Information
14.2.4. Government Initiatives
14.2.5. Regulations
14.2.6. Regulatory bodies
14.2.7. Major Associations
14.2.8. Taxes Levied
14.2.9. Corporate Tax Structure
14.2.10. Investments
14.2.11. Major Companies
14.3. North America Ventricular Assist Device Market, Historic Market Growth, 2017 - 2022, Value ($ Million)
14.4. North America Ventricular Assist Device Market, Forecast Market Growth, 2022 - 2027, 2032F Value ($ Million)
14.5. North America Ventricular Assist Device Market, Segmentation By Product, Historic And Forecast, 2017 - 2022, 2027F, 2032F, Value ($ Million)
14.6. North America Ventricular Assist Device Market, Segmentation By Application, Historic And Forecast, 2017 - 2022, 2027F, 2032F, Value ($ Million)
14.7. North America Ventricular Assist Device Market, Segmentation By End User, Historic And Forecast, 2017 - 2022, 2027F, 2032F, Value ($ Million)
14.8. North America Ventricular Assist Device Market: Country Analysis
14.9. USA Market
14.10. Summary
14.11. Market Overview
14.11.1. Country Information
14.11.2. Market Information
14.11.3. Background Information
14.11.4. Government Initiatives
14.11.5. Regulations
14.11.6. Regulatory bodies
14.11.7. Major Associations
14.11.8. Taxes Levied
14.11.9. Corporate Tax Structure
14.11.10. Investments
14.11.11. Major Companies
14.12. USA Ventricular Assist Device Market, Historic Market Growth, 2017 - 2022, Value ($ Million)
14.13. USA Ventricular Assist Device Market, Forecast Market Growth, 2022 - 2027, 2032F Value ($ Million)
14.14. USA Ventricular Assist Device Market, Segmentation By Product, Historic And Forecast, 2017 - 2022, 2027F, 2032F, Value ($ Million)
14.15. USA Ventricular Assist Device Market, Segmentation By Application, Historic And Forecast, 2017 - 2022, 2027F, 2032F, Value ($ Million)
14.16. USA Ventricular Assist Device Market, Segmentation By End User, Historic And Forecast, 2017 - 2022, 2027F, 2032F, Value ($ Million)
15. South America Market
15.1. Summary
15.2. Market Overview
15.2.1. Region Information
15.2.2. Market Information
15.2.3. Background Information
15.2.4. Government Initiatives
15.2.5. Regulations
15.2.6. Regulatory bodies
15.2.7. Major Associations
15.2.8. Taxes Levied
15.2.9. Corporate Tax Structure
15.2.10. Investments
15.2.11. Major Companies
15.3. South America Ventricular Assist Device Market, Historic Market Growth, 2017 - 2022, Value ($ Million)
15.4. South America Ventricular Assist Device Market, Forecast Market Growth, 2022 - 2027, 2032F Value ($ Million)
15.5. South America Ventricular Assist Device Market, Segmentation By Product, Historic And Forecast, 2017 - 2022, 2027F, 2032F, Value ($ Million)
15.6. South America Ventricular Assist Device Market, Segmentation By Application, Historic And Forecast, 2017 - 2022, 2027F, 2032F, Value ($ Million)
15.7. South America Ventricular Assist Device Market, Segmentation By End User, Historic And Forecast, 2017 - 2022, 2027F, 2032F, Value ($ Million)
15.8. South America Ventricular Assist Device Market: Country Analysis
15.9. Brazil Market
15.10. Brazil Ventricular Assist Device Market, Historic Market Growth, 2017 - 2022, Value ($ Million)
15.11. Brazil Ventricular Assist Device Market, Forecast Market Growth, 2022 - 2027, 2032F Value ($ Million)
15.12. Brazil Ventricular Assist Device Market, Segmentation By Product, Historic And Forecast, 2017 - 2022, 2027F, 2032F, Value ($ Million)
15.13. Brazil Ventricular Assist Device Market, Segmentation By Application, Historic And Forecast, 2017 - 2022, 2027F, 2032F, Value ($ Million)
15.14. Brazil Ventricular Assist Device Market, Segmentation By End User, Historic And Forecast, 2017 - 2022, 2027F, 2032F, Value ($ Million)
16. Middle East Market
16.1. Summary
16.2. Market Overview
16.2.1. Region Information
16.2.2. Market Information
16.2.3. Background Information
16.2.4. Government Initiatives
16.2.5. Regulations
16.2.6. Regulatory Bodies
16.2.7. Major Association
16.2.8. Taxes Levied
16.2.9. Corporate Tax Structure
16.2.10. Investments
16.2.11. Major Companies
16.3. Middle East Ventricular Assist Device Market, Historic Market Growth, 2017 - 2022, Value ($ Million)
16.4. Middle East Ventricular Assist Device Market, Forecast Market Growth, 2022 - 2027, 2032F Value ($ Million)
16.5. Middle East Ventricular Assist Device Market, Segmentation By Product, Historic And Forecast, 2017 - 2022, 2027F, 2032F, Value ($ Million)
16.6. Middle East Ventricular Assist Device Market, Segmentation By Application, Historic And Forecast, 2017 - 2022, 2027F, 2032F, Value ($ Million)
16.7. Middle East Ventricular Assist Device Market, Segmentation By End User, Historic And Forecast, 2017 - 2022, 2027F, 2032F, Value ($ Million)
17. Africa Market
17.1. Summary
17.2. Market Overview
17.2.1. Region Information
17.2.2. Market Information
17.2.3. Background Information
17.2.4. Government Initiatives
17.2.5. Regulations
17.2.6. Regulatory Bodies
17.2.7. Major Associations
17.2.8. Taxes Levied
17.2.9. Corporate Tax Structure
17.2.10. Investments
17.2.11. Major Companies
17.3. Africa Ventricular Assist Device Market, Historic Market Growth, 2017 - 2022, Value ($ Million)
17.4. Africa Ventricular Assist Device Market, Forecast Market Growth, 2022 - 2027, 2032F Value ($ Million)
17.5. Africa Ventricular Assist Device Market, Segmentation By Product, Historic And Forecast, 2017 - 2022, 2027F, 2032F, Value ($ Million)
17.6. Africa Ventricular Assist Device Market, Segmentation By Application, Historic And Forecast, 2017 - 2022, 2027F, 2032F, Value ($ Million)
17.7. Africa Ventricular Assist Device Market, Segmentation By End User, Historic And Forecast, 2017 - 2022, 2027F, 2032F, Value ($ Million)
18. Competitive Landscape and Company Profiles
19. Company Profiles
19.1. Abiomed, Inc
19.1.1. Company Overview
19.1.2. Products And Services
19.1.3. Business Strategy
19.1.4. Financial Overview
19.2. Abbott Laboratories
19.2.1. Company Overview
19.2.2. Products And Services
19.2.3. Business Strategy
19.2.4. Financial Overview
19.3. Medtronic plc
19.3.1. Company Overview
19.3.2. Products And Services
19.3.3. Business Strategy
19.3.4. Financial Overview
19.4. LivaNova PLC
19.4.1. Company Overview
19.4.2. Products And Services
19.4.3. Business Strategy
19.4.4. Financial Overview
19.5. Terumo Corporation
19.5.1. Company Overview
19.5.2. Products And Services
19.5.3. Financial Overview
20. Key Mergers and Acquisitions
20.1. Medtronic PLC Acquired Affera, Inc.
20.2. Boston Scientific Corporation Acquired Baylis Medical Company Inc.
20.3. Johnson & Johnson Acquired Abiomed
20.4. Royal Philips Acquired Cardiologs
20.5. ICU Medical Inc. Acquired Smiths Medical
20.6. Picard Medical, Inc. Acquired SynCardia System LLC
21. Opportunities And Strategies
21.1. Global Ventricular Assist Device Market In 2027 - Countries Offering Most New Opportunities
21.2. Global Ventricular Assist Device Market In 2027 - Segments Offering Most New Opportunities
21.3. Global Ventricular Assist Device Market In 2027 - Growth Strategies
21.3.1. Market Trend Based Strategies
21.3.2. Competitor Strategies
22. Ventricular Assist Device Market, Conclusions And Recommendations
22.1. Conclusions
22.2. Recommendations
22.2.1. Product
22.2.2. Place
22.2.3. Price
22.2.4. Promotion
22.2.5. People
23. Appendix
23.1. Market Data Sources
23.2. Research Methodology
23.3. Currencies
23.4. About the Publisher
23.5. Copyright and Disclaimer
Executive Summary
Ventricular Assist Device Global Market Opportunities And Strategies To 2032 provides the strategists; marketers and senior management with the critical information they need to assess the global ventricular assist device market as it emerges from the COVID-19 shut down.Reasons to Purchase
- Gain a truly global perspective with the most comprehensive report available on this market covering 12 geographies.
- Understand how the market is being affected by the coronavirus and how it is likely to emerge and grow as the impact of the virus abates.
- Create regional and country strategies on the basis of local data and analysis.
- Identify growth segments for investment.
- Outperform competitors using forecast data and the drivers and trends shaping the market.
- Understand customers based on the latest market research findings.
- Benchmark performance against key competitors.
- Utilize the relationships between key data sets for superior strategizing.
- Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
The report covers market characteristics; size and growth; segmentation; regional and country breakdowns; competitive landscape; market shares; trends and strategies for this market. It traces the market’s history and forecasts market growth by geography. It places the market within the context of the wider ventricular assist device market; and compares it with other markets.
The report covers the following chapters:
- Introduction and Market Characteristics
- Key Trends
- Global Market Size and Growth
- Regional Analysis
- Market Segmentation
- Regional Market Size and Growth
- Competitive Landscape
- Key Mergers and Acquisitions
- Market Opportunities And Strategies
- Conclusions And Recommendations
- Appendix
Scope
Markets Covered
1) By Product: Left Ventricular Assist Devices (LVADs); Right Ventricular Assist Devices (RVADs); Biventricular Assist Devices (BIVADs).2) By Type: Pulsatile Flow; Continuous Flow
3) By Design: Transcutaneous Ventricular Assist Devices; Implantable Ventricular Assist Devices
4) By Application: Bridge-To-Transplant (BTT) Therapy; Destination Therapy; Bridge-To-Recovery (BTR) Therapy; Bridge-To-Candidacy (BTC) Therapy
5) By End Users: Hospital; Ambulatory Surgical Centres; Cardiology Centres
Companies Mentioned: Abiomed; Abbott Laboratories; Medtronic; LivaNova PLC; Terumo Corporation
Countries: China; Australia; India; Indonesia; Japan; South Korea; USA; Brazil; France; Germany; UK; Russia
Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time-series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets; GDP proportions; expenditure per capita; ventricular assist device indicators comparison.
Data segmentations: country and regional historic and forecast data; market share of competitors; market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- Abiomed
- Abbott Laboratories
- Medtronic
- LivaNova PLC
- Terumo Corporation
Methodology
LOADING...
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 328 |
| Published | February 2023 |
| Forecast Period | 2022 - 2032 |
| Estimated Market Value ( USD | $ 1701.2 Million |
| Forecasted Market Value ( USD | $ 5295.8 Million |
| Compound Annual Growth Rate | 12.0% |
| Regions Covered | Global |
